{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:19:57Z","timestamp":1774138797266,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.tox.2003.10.013","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T07:03:31Z","timestamp":1071558211000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Organophosphate-induced convulsions and prevention of neuropathological damages"],"prefix":"10.1016","volume":"196","author":[{"given":"Kai","family":"Tuovinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2003.10.013_BIB1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ddr.430280304","article-title":"Purinoceptor nomenclature: a status report","volume":"28","author":"Abbracchio","year":"1993","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.tox.2003.10.013_BIB2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0009-8981(78)90322-4","article-title":"A new approach to determining cholinesterase activities in samples of whole blood","volume":"89","author":"Augustinsson","year":"1978","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tox.2003.10.013_BIB3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tox.2003.10.013_BIB4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00204-002-0395-x","article-title":"Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication","volume":"76","author":"Bueters","year":"2002","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2003.10.013_BIB5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/00001756-199405000-00022","article-title":"Inhibition of protein synthesis by the NMDA channel blocker MK-801","volume":"5","author":"Charriaut-Marlangue","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.tox.2003.10.013_BIB6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/taap.1998.8447","article-title":"Effect of MK-801 on seizures induced by exposure to hyperbaric oxygen: comparison with AP-7","volume":"151","author":"Chavko","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2003.10.013_BIB7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0014-4886(95)90016-0","article-title":"Transient changes in Fos and GFAP immunoreactivity precede neuronal loss in the rat hippocampus following neonatal anoxia","volume":"131","author":"Dell\u2019Anna","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tox.2003.10.013_BIB8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2003.10.013_BIB9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/096032719501400304","article-title":"Sarin-induced neuropathology in rats","volume":"14","author":"Kadar","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2003.10.013_BIB10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0306-3623(89)90333-9","article-title":"Cold exposure decreases the effectiveness of atropine-oxime treatment in organophosphate intoxication in rats and mice","volume":"20","author":"Kaliste-Korhonen","year":"1989","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.tox.2003.10.013_BIB11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1476-5381.1993.tb13905.x","article-title":"Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes","volume":"110","author":"Kirkpatrick","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2003.10.013_BIB12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(93)91270-3","article-title":"Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an \u03c93 site ligand","volume":"618","author":"Lallement","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.tox.2003.10.013_BIB13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002040050595","article-title":"Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support","volume":"73","author":"Lallement","year":"1999","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2003.10.013_BIB14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/faat.1996.0012","article-title":"Triphenyl phosphite and diisopropylphosphorofluoridate produce separate and distinct axonal degeneration patterns in the central nervous system of the rat","volume":"29","author":"Lehning","year":"1996","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2003.10.013_BIB15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0306-3623(97)00455-2","article-title":"Protection by an adenosine analogue against kainate-induced extrahippocampal neuropathology","volume":"31","author":"MacGregor","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.tox.2003.10.013_BIB16","unstructured":"Marrs, T.C., Maynard, R.L., Sidell, F.R., 1996. Treatment and prophylaxis of organophosphate nerve agent poisoning. In: D. Anderson (Ed.), Chemical Warfare Agents: Toxicology and Treatments, Wiley, West Sussex, pp. 101\u2013113."},{"key":"10.1016\/j.tox.2003.10.013_BIB17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00904-0","article-title":"Spin trapping agent phenyl-N-tert-butylnitrone prevents diisopropylphosphorofluoridate-induced excitotoxicity in skeletal muscle of the rat","volume":"278","author":"Milatovic","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2003.10.013_BIB18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0161-813X(00)00015-2","article-title":"Effects of Huperzine used as pre-treatment against soman-induced seizures","volume":"22","author":"Tonduli","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2003.10.013_BIB19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/01480549809007409","article-title":"New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release","volume":"21","author":"Van Helden","year":"1998","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2003.10.013_BIB20","first-page":"438","article-title":"Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning","volume":"20","author":"Van Helden","year":"1999","journal-title":"TiPS"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:47:52Z","timestamp":1759531672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X03004992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0300483X03004992"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2003.10.013","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organophosphate-induced convulsions and prevention of neuropathological damages","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2003.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}